Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Canonica

Showing results (21-30 of 430) with videos related to

Pageof 43
Sort By:
Lancet (London, England)|May 28, 1988
Food allergy and dyspepsiaG W Canonica, G Ciprandi
Allergy|September 25, 2002
Treating the allergic patient: think globally, treat globallyG Passalacqua, G W Canonica
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 7, 2001
Allergen-specific sublingual immunotherapy for respiratory allergyG Passalacqua, G W Canonica
The New England Journal of Medicine|May 23, 2001
Inhaled triamcinolone and chronic obstructive pulmonary diseaseA De Maria, G W Canonica
Allergy|August 2, 2000
Sublingual IT in OASC Lombardi, G W Canonica, G Passalacqua
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 12, 1999
Effects of H1 antihistamines on adhesion molecules: a possible rationale for long-term treatmentG Ciprandi, G Passalacqua, G W Canonica
American Journal of Rhinology|November 9, 2000
Nonsteroidal antiallergic treatments in allergic rhinitisG W Canonica, G Ciprandi, G Passalacqua
Respiratory Research|February 12, 2017
Erratum to: Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?F Blasi, G W Canonica, M Miravitlles
Respiratory Research|January 20, 2017
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?F Blasi, G W Canonica, M Miravitlles
Pulmonary Pharmacology & Therapeutics|September 27, 2012
From "blockbusters" to "biosimilars": an opportunity for patients, medical specialists and health care providersF Braido, S Holgate, G W Canonica
Pageof 43

Showing results (21-30 of 430) with videos related to

Sort By:
Pageof 43
Lancet (London, England)|May 28, 1988
Food allergy and dyspepsiaG W Canonica, G Ciprandi
Allergy|September 25, 2002
Treating the allergic patient: think globally, treat globallyG Passalacqua, G W Canonica
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 7, 2001
Allergen-specific sublingual immunotherapy for respiratory allergyG Passalacqua, G W Canonica
The New England Journal of Medicine|May 23, 2001
Inhaled triamcinolone and chronic obstructive pulmonary diseaseA De Maria, G W Canonica
Allergy|August 2, 2000
Sublingual IT in OASC Lombardi, G W Canonica, G Passalacqua
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 12, 1999
Effects of H1 antihistamines on adhesion molecules: a possible rationale for long-term treatmentG Ciprandi, G Passalacqua, G W Canonica
American Journal of Rhinology|November 9, 2000
Nonsteroidal antiallergic treatments in allergic rhinitisG W Canonica, G Ciprandi, G Passalacqua
Respiratory Research|February 12, 2017
Erratum to: Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?F Blasi, G W Canonica, M Miravitlles
Respiratory Research|January 20, 2017
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?F Blasi, G W Canonica, M Miravitlles
Pulmonary Pharmacology & Therapeutics|September 27, 2012
From "blockbusters" to "biosimilars": an opportunity for patients, medical specialists and health care providersF Braido, S Holgate, G W Canonica
Pageof 43